Trial Profile
A Phase 2, Multi-center, Randomized, Double-blinded, Placebo-controlled Study to Assess Efficacy of 3'-Aminomethylnicotine-P.Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) in Smokers Who Want to Quit Smoking
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2016
Price :
$35
*
At a glance
- Drugs Nicotine abuse vaccine (Primary)
- Indications Smoking withdrawal; Substance-related disorders
- Focus Pharmacodynamics; Therapeutic Use
- 03 Nov 2008 Planned end date changed from 1 Oct 2007 to 1 Nov 2008, based on information from ClinicalTrials.gov.
- 03 May 2007 Status changed from initiated to in progress.
- 08 Jun 2006 New trial record.